Global Market: Malaysia's Asia OneHealthcare files draft prospectus for IPO of up to 4.38 billion shares - IndiaIPO
Global Market: Malaysia's Asia OneHealthcare files draft prospectus for IPO of up to 4.38 billion shares IndiaIPO
Gynofem Healthcare Price · Health Care · Gynofem Healthcare Unlisted / Pre-IPO Share Price
As of 29 Oct 2026, the Gynofem Healthcare Price unlisted share price is ₹64 per share. Gynofem Healthcare Price is an unlisted / pre-IPO company — not listed on NSE or BSE. Minimum investment: ₹50,000. ISIN: INE0NLL01017.
▲ ₹0.64 (+1.01%) over all time
Key figures for Gynofem Healthcare Price
Gynofem Healthcare Private Limited is an Indian pharmaceutical and healthcare company focused on women’s health, gynaecology and allied therapeutics. Public profiles list prescription brands and nutraceuticals addressing reproductive health, hormonal support and related conditions. The company’s materials reference compliance with Indian drug regulations, quality systems and medical engagement through scientific information and practitioner outreach. Gynofem distributes through a network of stockists and pharmacies, expanding presence in key markets. As an emerging enterprise, it emphasises affordability, patient-centric communication and responsible promotion practices in collaboration with healthcare professionals. Information is summarised from the company's official website and credible profiles.
| Particulars | FY25 | FY26 LATEST |
|---|---|---|
| Revenue | 494.3 | 501.7▲1% |
| EBITDA | -111.8 | -43.5▲61% |
| OPM (%) | -22.62% | -8.65%▲62% |
| PBT | -179 | -115.5▲35% |
| PAT | -209.3 | -134.9▲36% |
| EPS (₹) | ₹-0.21 | ₹-0.14▲33% |
Figures in ₹ Crore unless marked ₹ (per share) or %. Source: company filings via unlistedzone.
Gynofem Healthcare shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Gynofem Healthcare is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Gynofem Healthcareshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Gynofem Healthcare has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Gynofem Healthcare is INE0NLL01017. Contact our desk for the latest status and a live quote before you invest.
Gynofem Healthcare Price is an unlisted company operating in the Health Care sector (Pharmaceuticals/OTC). Gynofem Healthcare Private Limited is an Indian pharmaceutical and healthcare company focused on women’s health, gynaecology and allied therapeutics. Public profiles list prescription brands and nutraceuticals addressing reproductive health, hormonal support and related conditions. The company’s mat…
The current unlisted market price is ₹63.36 per share. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Global Market: Malaysia's Asia OneHealthcare files draft prospectus for IPO of up to 4.38 billion shares IndiaIPO
Sanofi Consumer share price jumps 11% after strong Q3 results | Is it time to book profits? Check target, rationale Livemint
Hero Motors shares: 3 back-to-back upper circuits! Stock jumps 46% from IPO issue price - Should you buy? Livemint
As of 29 Oct 2026, the Gynofem Healthcare unlisted (pre-IPO) share price is ₹64 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy Gynofem Healthcare unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Gynofem Healthcare is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Gynofem Healthcare has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Gynofem Healthcare.
The ISIN for Gynofem Healthcare unlisted shares is INE0NLL01017. You will need this ISIN when the shares are credited to your demat account.
Gynofem Healthcare unlisted shares have a face value of ₹10 and a typical minimum lot of 1000 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Gynofem Healthcare price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Gynofem Healthcare can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Gynofem Healthcare.
Unlisted shares like Gynofem Healthcare are high-growth but illiquid. Balance them with these — all with the same SEBI-registered team.